Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04235699 · ClinicalTrials.gov registry record · NA

Ketogenic Diet in Patients With Heart Failure

A NA study, sponsored by Ohio State University.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT04235699: Clinical Trial NA study, sponsored by Ohio State University.

NCT04235699 is a NA study that was terminated before completion, run by Ohio State University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04235699, a NA study, was terminated before completion, sponsored by Ohio State University.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

This study is being done to evaluate the effects of a low carbohydrate ketogenic diet on exercise tolerance in patients with Heart Failure with Preserved Ejection Fraction (HFpEF), also known as Diastolic Heart Failure (DHF).

Primary Outcome

Participants will undergo VO2 max testing, conducted by trained professionals. VO2 max testing analyses will determine changes in maximal exercise performance

Interventions

  • OTHER Nutritional and Dietary Manipulation

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2019-12-22
Est. Completion 2022-12-31
Phase NA
Ohio State University

552 total trials

Why NCT04235699 stopped before completion

NCT04235699 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Nutritional and Dietary Manipulation is the first listed.

NCT04235699 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04235699 about?

NCT04235699 is a clinical study titled "Ketogenic Diet in Patients With Heart Failure". This study is being done to evaluate the effects of a low carbohydrate ketogenic diet on exercise tolerance in patients with Heart Failure with Preserved Ejection Fraction (HFpEF), also known as Diastolic Heart Failure (DHF).

What is the current status of trial NCT04235699?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-12-22. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT04235699?

The interventions under investigation include: Nutritional and Dietary Manipulation (OTHER).

Who is sponsoring clinical trial NCT04235699?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04235699's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04235699, the US trial registry maintained by the National Library of Medicine. NCT04235699 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.